CNBC: Moderna says preliminary trial data shows its coronavirus vaccine is more than 94% effective, shares soar
Moderna said preliminary phase three trial data shows its coronavirus vaccine is more than 94% effective in preventing Covid-19.
The Moderna vaccine is much easier to store than the Pfizer vaccine, which was announced to be 90% effective last week.
The Moderna vaccine is 94.5% effective against coronavirus, according to early data released by the company, making it the second vaccine in the US to have a stunningly high success rate. @ElizCohenCNN reports. https://t.co/9daC46IbZn pic.twitter.com/49TX73O81U
— CNN (@CNN) November 16, 2020
